Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans

Nephrology Dialysis Transplantation

Volumn 27, Issue 4, 2012, Pages 1505-1511

  Cooke, Jessica N ^a   Bostrom, Meredith A ^a   Hicks, Pamela J ^a   Ng, Maggie C Y ^a   Hellwege, Jacklyn N ^a   Comeau, Mary E ^a   Divers, Jasmin ^a   Langefeld, Carl D ^a   Freedman, Barry I ^a   Bowden, Donald W ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

APOL1; diabetic nephropathy; end stage renal disease; MYH9; type 2 diabetes mellitus

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; APOL 1 GENE; ARTICLE; CHROMOSOME 22Q; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EUROPEAN AMERICAN; FEMALE; GENE; GENE DELETION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NON MUSCLE MYOSIN IIA GENE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; COHORT STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MOLECULAR MOTOR PROTEINS; MYOSIN HEAVY CHAINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS;

EID: 84859314693     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr522     Document Type: Article

References (29)

1. U.S. Renal Data System. USRDS 2009 Annual Data Report. Atlas of chronic kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2009
2. Bowden DW. Genetics of kidney disease. Kidney Int Suppl 2003; 83: S8-S12 (Pubitemid 36126835)
3. O'Dea DF, Murphy SW, Hefferton D et al. Higher risk for renal failure in first-degree relatives of white patients with end-stage renal disease: a population-based study. Am J Kidney Dis 1998; 32: 794-801 (Pubitemid 28516310)
4. Spray BJ, Atassi NG, Tuttle AB et al. Familial risk, age at onset, and cause of end-stage renal disease in white Americans. J Am Soc Nephrol 1995; 5: 1806-1810
5. Satko SG, Sedor JR, Iyengar SK et al. Familial clustering of chronic kidney disease. Semin Dial 2007; 20: 229-236
6. Arrondel C, Vodovar N, Knebelmann B et al. Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes. J Am Soc Nephrol 2002; 13: 65-74 (Pubitemid 34042012)
7. Singh N, Nainani N, Arora P et al. CKD in MYH9-related disorders. Am J Kidney Dis 2009; 54: 732-740
8. Freedman BI, Hicks PJ, Bostrom MA et al. Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD. Nephrol Dial Transplant 2009; 24: 3366-3371
9. Freedman BI, Kopp JB, Winkler CA et al. Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study. Am J Nephrol 2009; 29: 626-632
10. Kao WH, Klag MJ, Meoni LA et al. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 2008; 40: 1185-1192
11. Kopp JB, SmithMW, NelsonGWet al. MYH9 is amajor-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 2008; 40: 1175-1184
12. O'Seaghdha CM, Parekh RS, Hwang SJ et al. The MYH9/APOL1 region and chronic kidney disease in European-Americans. Hum Mol Genet 2011; 20: 2450-2456
13. Behar DM, Rosset S, Tzur S et al. African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans. Hum Mol Genet 19: 1816-1827
14. Pattaro C, Aulchenko YS, Isaacs A et al. Genome-wide linkage analysis of serum creatinine in three isolated European populations. Kidney Int 2009; 76: 297-306
15. Freedman BI, Kopp JB, Langefeld CD et al. The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. J Am Soc Nephrol 2010; 21: 1422-1426
16. Genovese G, Friedman DJ, Ross MD et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329: 841-845
17. Genovese G, Tonna SJ, Knob AU et al. A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9. Kidney Int 2010; 78: 698-704
18. Tzur S, Rosset S, Shemer R et al. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet 2010; 128: 345-350
19. Keene KL, Mychaleckyj JC, Leak TS et al. Exploration of the utility of ancestry informative markers for genetic association studies of African Americans with type 2 diabetes and end stage renal disease. Hum Genet 2008; 124: 147-154
20. Tang H, Peng J, Wang P et al. Estimation of individual admixture: analytical and study design considerations. Genet Epidemiol 2005; 28: 289-301 (Pubitemid 40559542)
21. Bento JL, Palmer ND, Zhong M et al. Heterogeneity in gene loci associated with type 2 diabetes on human chromosome 20q13.1. Genomics 2008; 92: 226-234
22. Gopalakrishnan I, Iskandar SS, Daeihagh P et al. Coincident idiopathic focal segmental glomerulosclerosis collapsing variant and diabetic nephropathy in an African American homozygous for MYH9 risk variants. Hum Pathol 2011; 42: 291-294
23. Pezzolesi MG, Poznik GD, Mychaleckyj JC et al. Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes. Diabetes 2009; 58: 1403-1410
24. Kottgen A, Hwang SJ, Rampersaud E et al. TCF7L2 variants associate with CKD progression and renal function in population-based cohorts. J Am Soc Nephrol 2008; 19: 1989-1999
25. Leak TS, Perlegas PS, Smith SG et al. Variants in intron 13 of the ELMO1 gene are associated with diabetic nephropathy in African Americans. Ann Hum Genet 2009; 73: 152-159
26. Maeda S, Kobayashi MA, Araki S et al. A single nucleotide polymorphism within the acetyl-coenzyme A carboxylase beta gene is associated with proteinuria in patients with type 2 diabetes. PLoS Genet 2010; 6: e1000842
27. Pezzolesi MG, Katavetin P, Kure M et al. Confirmation of genetic associations at ELMO1 in the GoKinD collection supports its role as a susceptibility gene in diabetic nephropathy. Diabetes 2009; 58: 2698-2702
28. Shimazaki A, Kawamura Y, Kanazawa A et al. Genetic variations in the gene encoding ELMO1 are associated with susceptibility to diabetic nephropathy. Diabetes 2005; 54: 1171-1178 (Pubitemid 40446333)
29. Yoshida T, Kato K, Yokoi K et al. Association of genetic variants with myocardial infarction in individuals with or without hypertension or diabetes mellitus. Int J Mol Med 2009; 24: 701-709